tirzepatide stalled weight loss on Tirzepatide? Why It Happens and How to Get Results Again tirzepatide stalled weight loss Tirzepatide

Hill stresses that these uses are still being studied, and so far, evidence is limited or inconclusive

Tchakonte et al., 2023) and as a food source for predators (Gilioli et al., 2017) may reduce biodiversity

Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1based therapies

Weaknesses include pricing that surfaces mainly after intake, wide cost variance, and prescribing from a questionnaire without reading your genetics

Weight loss Trulicity (dulaglutide) leads to some weight loss, but it is a secondary benefit of the medication

doi: 10.3389/fnagi.2025.1665957 Received 14 July 2025 Accepted 25 September 2025 Published 10 October 2025 Volume 17 - 2025 Edited by Indrani Poddar, University of Minnesota Twin Cities, United States Reviewed by Shikha Grover, Dyne Therapeutics, United States Ayush Kumar Srivastava, SUNY Potsdam, United States Updates Copyright 2025 Invernizzi, Ciocca, Contaldi, Inverso, Calandrella, Mignone, Barichella, Isaias and Pezzoli